ENXTBR:ABI
ENXTBR:ABIBeverage

Should Investors Reassess AB InBev Amid 8.5% Year-to-Date Climb and Brand Strategy Shift?

Wondering if now is the right time to get into Anheuser-Busch InBev? You are not alone, as interest around this iconic brewer keeps bubbling up in investor circles. The stock has caught a mild tailwind lately, recording a 4.4% gain over the last month and an 8.5% rise year-to-date. Its one-year return remains slightly negative at -2.9%. These recent moves come as global headlines focus on consumer trends in beer and the company’s brand strategy revamp. This has fueled both optimism and...
ENXTBR:ARGX
ENXTBR:ARGXBiotechs

argenix (ENXTBR:ARGX): Exploring Valuation After Recent Share Price Momentum and Pipeline Updates

argenx (ENXTBR:ARGX) has seen its stock trend modestly higher over the past month. Investors appear to be tracking recent performance numbers and considering how the company’s growth trajectory might influence valuation in the current environment. See our latest analysis for argenx. argenx’s 30-day share price return of 6.7% signals renewed momentum and builds on a robust 20.8% gain over the last 90 days. The company’s one-year total shareholder return now stands at nearly 28%, highlighting...
ENXTBR:MELE
ENXTBR:MELESemiconductor

Are We Seeing the First Signs of Operational Strain at Melexis (ENXTBR:MELE)?

Melexis NV reported its third quarter 2025 results, showing sales of €215.29 million and net income of €27.53 million, both significantly lower than the same period a year ago. The contraction in sales and profit indicates the company may be encountering operational or market challenges over the year so far. We’ll examine how reduced earnings for the quarter are influencing Melexis’ investment narrative and outlook for operational momentum. The end of cancer? These 29 emerging AI stocks are...
ENXTBR:DEME
ENXTBR:DEMEConstruction

A Look at DEME Group's (ENXTBR:DEME) Valuation Following Landmark Brazilian Port Concession Win

DEME Group (ENXTBR:DEME) has won Brazil’s inaugural auction for a port access channel concession, in partnership with FTS Participacoes Societarias. This 25-year contract covers operations and expansion at the vital Port of Parana. See our latest analysis for DEME Group. DEME Group’s announcement of the major Brazilian port concession appears to have reignited market attention, with a strong 6.6% share price return over the past month after a mixed year. While year-to-date returns remain...
ENXTBR:ABI
ENXTBR:ABIBeverage

Anheuser-Busch InBev (ENXTBR:ABI) Profit Margin Rises to 12.2%, Reinforcing Bullish Valuation Narratives

Anheuser-Busch InBev (ENXTBR:ABI) posted a net profit margin of 12.2% for the most recent period, a jump from last year’s 9.9%. Over the past five years, the company has averaged 24.5% annual earnings growth, with current-year earnings up 20%. Although this is not as rapid as previous years, it is still growing. With analysts forecasting another 10.03% per year in earnings growth and the stock trading well below consensus fair value estimates, investors are likely to see the current...
ENXTBR:ARGX
ENXTBR:ARGXBiotechs

argenx (ENXTBR:ARGX) Profitability Confirms Strong Growth Narrative, But Valuation Debates Persist

argenx (ENXTBR:ARGX) has achieved a notable turnaround to profitability over the past year, posting high-quality earnings and sustaining a five-year annual earnings growth rate of 52.7%. Looking ahead, consensus forecasts point to annual earnings growth of 28%, outpacing the Belgian market’s 15.6% projection, while revenue is also expected to rise by 18.5% per year compared to an 8.4% market average. Investors are weighing these strong growth figures and recent profitability against...
ENXTBR:AED
ENXTBR:AEDHealth Care REITs

How Raised 2025 Guidance and Solid Results at Aedifica (ENXTBR:AED) Have Changed Its Investment Story

Aedifica announced in late October that it has raised its 2025 earnings guidance and reported solid nine-month results, with sales reaching €271.79 million and net income of €194.12 million. A key highlight is the 3.1% like-for-like rental income growth, reflecting improved operational momentum alongside continued asset rotation and new investment initiatives. We'll explore how the uplifted earnings forecast reinforces Aedifica's investment narrative and signals continued operating momentum...
ENXTBR:CENER
ENXTBR:CENERElectrical

A Fresh Look at Cenergy Holdings (ENXTBR:CENER) Valuation Following Its Recent 71% Shareholder Return

Cenergy Holdings (ENXTBR:CENER) has quietly posted some eye-catching returns over the past year, with shares climbing more than 70%. This strong momentum puts the stock in focus for investors who want to understand what is driving its performance. See our latest analysis for Cenergy Holdings. Cenergy Holdings’ 71% total shareholder return over the past year stands out against a backdrop of accelerating momentum. The company has also seen a 36.7% share price return in the last 90 days and...
ENXTBR:CMBT
ENXTBR:CMBTOil and Gas

How Fleet Renewal and Vessel Sales Will Impact Cmb.Tech's (ENXTBR:CMBT) Long-Term Competitiveness

In recent announcements, Cmb.Tech NV reported the delivery of five newbuilding vessels across several categories and revealed the sale of multiple ships, generating significant capital gains set for the third and fourth quarters of 2025. These developments highlight how Cmb.Tech is actively renewing its fleet and managing assets to support operational improvements and future revenue stability. To understand the impact on Cmb.Tech's investment narrative, we will examine how these fleet...
ENXTBR:AED
ENXTBR:AEDHealth Care REITs

Aedifica (ENXTBR:AED) Profit Margin Doubles, Reinforcing Bullish Narratives on Earnings Quality

Aedifica (ENXTBR:AED) posted a net profit margin of 62.1%, doubling last year’s margin of 31.1%. EPS growth soared by 115.1% as the company rebounded from a 5-year annual decline of 10.7%. Revenue is forecast to grow 3% annually, below the Belgian market's 8.4%, but earnings are projected to climb 18.8% per year, outpacing the market's 15.6% rate. Positive investor sentiment is likely to focus on the strong momentum in profitability and attractive valuation metrics, even as financial...
ENXTBR:SOLB
ENXTBR:SOLBChemicals

Solvay (ENXTBR:SOLB) Valuation in Focus as Bio-Based Polymer Advances Gain Industry Attention

Solvay (ENXTBR:SOLB) is garnering attention as its advancements in bio-based and recyclable polymer technologies align with France’s fast-evolving market and regulatory push for circular economy solutions. Investors are watching how these initiatives shape long-term value. See our latest analysis for Solvay. Solvay’s recent advances in sustainable polymers come at an interesting time for shareholders, given the stock’s hefty 13.44% decline in share price so far this year. While the 1-year...
ENXTBR:COFB
ENXTBR:COFBHealth Care REITs

Cofinimmo (ENXTBR:COFB) Returns to Profitability Despite €52.6 Million Non-Recurring Loss

Cofinimmo (ENXTBR:COFB) reported a 20.9% annual decline in earnings over the past five years, but has just moved back into profitability despite a significant non-recurring loss of €52.6 million for the 12 months ending September 2025. Looking ahead, company earnings are forecast to grow at 13.1% per year, trailing the Belgian market average of 15.3%, while revenue is expected to decrease at an annual rate of -1.1% over the next three years. See our full analysis for Cofinimmo. Let’s see how...
ENXTBR:CMBT
ENXTBR:CMBTOil and Gas

Cmb.Tech (ENXTBR:CMBT): Assessing Valuation as Investor Sentiment Shifts

Cmb.Tech (ENXTBR:CMBT) stock is catching investors’ attention today as recent trading patterns point to shifts in sentiment. Shares have seen mixed returns lately, bringing valuation and future prospects into sharper focus for the market. See our latest analysis for Cmb.Tech. While Cmb.Tech’s share price ticked higher over the past quarter, overall momentum has cooled, with a recent one-year total shareholder return of -41.5%. Investors seem to be weighing past volatility against the...